Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Enterprise Value (2020 - 2026)

Updated

Aligos Therapeutics' Enterprise Value was $27.8 million in Q3 2026, compared with $2.52 million a year earlier and down 6.7% from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) Enterprise Value (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Aligos Therapeutics' Enterprise Value was -$277.93 million through Sep 30, 2026; for FY2025, it was $14.33 million, down 92.6% from FY2024.

  • Enterprise Value shows a five-year compound annual growth rate of -70.7% (FY2020 to FY2025).
  • In earlier years, Enterprise Value was $192.68 million in FY2024 (-79.3%), $931.03 million in FY2023 (+3.8%), $897.05 million in FY2022 (-92.8%) and $12.46 billion in FY2021 (+87.1%).
  • Quarterly Enterprise Value has moved between -$68.53 million (Q1 2025) and $12.46 billion (Q4 2021) over five years.
  • The best year-over-year quarter for Enterprise Value over five years was Q1 2024 (growth of 344.8%); the worst was Q2 2022 (a decline of 94.1%).
  • Per Business Quant data, ALGS's Enterprise Value in the three quarters before Q3 2026 was $29.79 million (Q2 2026), $22.39 million (Q1 2026) and $14.33 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Aligos Therapeutics 21.97 Mn -314.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 27.80 Mn
Jun 30, 2026 29.79 Mn
Mar 31, 2026 22.39 Mn
Dec 31, 2025 14.33 Mn
Sep 30, 2025 2.52 Mn
Jun 30, 2025 -48.27 Mn
Mar 31, 2025 -68.53 Mn
Dec 31, 2024 192.68 Mn
Sep 30, 2024 -20.58 Mn
Jun 30, 2024 1.27 Bn
Mar 31, 2024 3.71 Bn
Dec 31, 2023 931.03 Mn
Sep 30, 2023 741.79 Mn
Jun 30, 2023 965.01 Mn
Mar 31, 2023 834.74 Mn
Dec 31, 2022 897.05 Mn
Sep 30, 2022 1.04 Bn
Jun 30, 2022 1.14 Bn
Mar 31, 2022 2.11 Bn
Dec 31, 2021 12.46 Bn
API Access

Aligos Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=ALGS&period=max&api_key=YOUR_API_KEY